Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 376 AL 390

An Overview of Primary Dementias as Clinicopathological Entities

Salardini A.

Semin Neurol. 2019 Apr;39(2):153-166. doi: 10.1055/s-0039-1683445. Epub 2019 Mar 29.

Recent Advances in Apoptosis: THE Role of Hydrazones

Çıkla-Süzgün P, Küçükgüzel ŞG.

Mini Rev Med Chem. 2019;19(17):1427-1442. doi: 10.2174/1389557519666190410125910.

Emerging drugs for progressive supranuclear palsy

Giagkou N, Stamelou M.

Expert Opin Emerg Drugs. 2019 Jun;24(2):83-92. doi: 10.1080/14728214.2019.1609450. Epub 2019 May 20.

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Staff NP, Jones DT, Singer W.

Mayo Clin Proc. 2019 May;94(5):892-905. doi: 10.1016/j.mayocp.2019.01.001.

Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial

Cheng ST, Chan WC, Lam LCW.

Am J Geriatr Psychiatry. 2019 Sep;27(9):984-994. doi: 10.1016/j.jagp.2019.03.013. Epub 2019 Mar 26.

Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases

Nishibori M, Mori S, Takahashi HK.

J Pharmacol Sci. 2019 May;140(1):94-101. doi: 10.1016/j.jphs.2019.04.006. Epub 2019 May 4.

Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models

Feng ST, Wang ZZ, Yuan YH, Sun HM, Chen NH, Zhang Y.

Pharmacol Res. 2019 Aug;146:104336. doi: 10.1016/j.phrs.2019.104336. Epub 2019 Jul 2.

Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease

Nakajima A, Ohizumi Y.

Int J Mol Sci. 2019 Jul 10;20(14):3380. doi: 10.3390/ijms20143380.

Neuro-regeneration Therapeutic for Alzheimer's Dementia: Perspectives on Neurotrophic Activity

Sun MK, Alkon DL.

Trends Pharmacol Sci. 2019 Sep;40(9):655-668. doi: 10.1016/j.tips.2019.07.008. Epub 2019 Aug 8.

Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases

Mathew B, Parambi DGT, Mathew GE, Uddin MS, Inasu ST, Kim H, Marathakam A, Unnikrishnan MK, Carradori S.

Arch Pharm (Weinheim). 2019 Nov;352(11):e1900177. doi: 10.1002/ardp.201900177. Epub 2019 Sep 3.

Natural Products as Modulators of the Proteostasis Machinery: Implications in Neurodegenerative Diseases

Cuanalo-Contreras K, Moreno-Gonzalez I.

Int J Mol Sci. 2019 Sep 20;20(19):4666. doi: 10.3390/ijms20194666.

Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review

Berman MH, Nichols TW.

Photobiomodul Photomed Laser Surg. 2019 Oct;37(10):623-634. doi: 10.1089/photob.2019.4685.

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

Husain I, Zameer S, Madaan T, Minhaj A, Ahmad W, Iqubaal A, Ali A, Najmi AK.

Metab Brain Dis. 2019 Aug;34(4):957-965. doi: 10.1007/s11011-019-00400-9. Epub 2019 Mar 8.

Small molecules as therapeutic drugs for Alzheimer's disease

Oliver DMA, Reddy PH.

Mol Cell Neurosci. 2019 Apr;96:47-62. doi: 10.1016/j.mcn.2019.03.001. Epub 2019 Mar 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias